Pluristem and Korea's CHA in $10.4m stem cell collaboration - Globes

Pluristem and Korea s CHA in $10.4m stem cell collaborationGlobesStem cell developer Pluristem Therapeutics Ltd. (Nasdaq:PSTI; DAX: PJT: PLTR) and Korea s CHA Bio&Diostech (Kodaq: CHA) are pushing forward with the strategic partnership agreement reached in June. The two companies have concluded a mutual Pluristem Therapeutics Inc. : Pluristem and CHA Move Forward on Strategic 4-traders (press [ ]

http://blog.zandcell.com/pluristem-and-koreas-cha-in-10-4m-stem-cell-collaboration-globes/?utm_source=rss&utm_medium=rss&utm_campaign=pluristem-and-koreas-cha-in-10-4m-stem-cell-collaboration-globes